Eli Lilly to Finalize $2 Billion Agreement with Insilico Medicine for Diabetes Drug

Eli Lilly to Finalize $2 Billion Agreement with Insilico Medicine for Diabetes Drug

Synopsis

Lilly ‌will ​acquire ​exclusive ⁠rights to sell a ​GLP-1 drug for diabetes ​from Insilico Medicine, the FT ‌report said, citing sources familiar ​with ​the ⁠matter.
Eli Lilly will sign a $2 billion deal with Hong Kong-listed ‌biotech ⁠Insilico ⁠Medicine , which uses artificial intelligence for drug discovery, the Financial Times reported ⁠on Sunday.

Lilly ‌will ​acquire ​exclusive ⁠rights to sell a ​GLP-1 drug for diabetes ​from Insilico Medicine, the FT ‌report said, citing sources familiar ​with ​the ⁠matter.

Reuters could not immediately verify the report.
COMPANIES

PetroChina Profit Drops on Lower Oil Cost, Weak Fuel Demand
STORY

Snabbit Hits Milestone of 1 Million Orders in March Amid Rising Demand for Home Services

 STORY

Stanford Study Highlights Risks of Chatbots Affirming Harmful User Behavior

 COMPANIES

Dr Reddy’s gets 30 days to sell ‘Olymviq’ stock in Novo trademark case

Latest Briefs

Fast updates from the latest stories.

Bombay High Court Proposes Mediation in Kalyani Family Wealth Dispute
COMPANIES
Bombay High Court Proposes Mediation in Kalyani Family Wealth Dispute
Mar 29, 2026
Swiss Favor Stricter Social Media Regulations for Youths Amid Global Scrutiny
NEWS
Swiss Favor Stricter Social Media Regulations for Youths Amid Global Scrutiny
Mar 29, 2026
As Jewar gears up, Delhi airport firm seeks jet fuel tax parity to stay in the game
COMPANIES
As Jewar gears up, Delhi airport firm seeks jet fuel tax parity to stay in the game
Mar 29, 2026
Monika Bickert, Meta's Content Policy Chief, to Depart for Harvard Law School
NEWS
Monika Bickert, Meta's Content Policy Chief, to Depart for Harvard Law School
Mar 29, 2026
NVIDIA Unveils NeMoClaw: A New Era for Enterprise AI Frameworks
IN-DEPTH +1
NVIDIA Unveils NeMoClaw: A New Era for Enterprise AI Frameworks
Mar 29, 2026
Leela Palaces ramps up expansion to tap India’s booming luxury travel
COMPANIES
Leela Palaces ramps up expansion to tap India’s booming luxury travel
Mar 29, 2026
Vedanta's Anil Agarwal invokes Gita in first statement on Jaypee bid reversal: ‘We have no attachment to this asset’
COMPANIES
Vedanta's Anil Agarwal invokes Gita in first statement on Jaypee bid reversal: ‘We have no attachment to this asset’
Mar 29, 2026
AMD to Launch Helios GPU Platform in India by Late 2026
NEWS
AMD to Launch Helios GPU Platform in India by Late 2026
Mar 29, 2026